Browsing byAuthorBarnham, KJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2021-09-29Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, ECL; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA
2017-06-28The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseFinkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, EC; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA
2014-01-01Oral treatment with Cu<sup>II</sup>(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosisRoberts, BR; Lim, NKH; McAllum, EJ; Donnelly, PS; Hare, DJ; Doble, PA; Turner, BJ; Price, KA; Lim, SC; Paterson, BM; Hickey, JL; Rhoads, TW; Williams, JR; Kanninen, KM; Hung, LW; Liddell, JR; Grubman, A; Monty, JF; Llanos, RM; Kramer, DR; Mercer, JFB; Bush, AI; Masters, CL; Duce, JA; Li, QX; Beckman, JS; Barnham, KJ; White, AR; Crouch, PJ
2015-01-01Stabilization of nontoxic Ajβ-oligomers: Insights into the mechanism of action of hydroxyquinolines in alzheimer’s diseaseRyan, TM; Roberts, BR; McColl, G; Hare, DJ; Doble, PA; Li, QX; Lind, M; Roberts, AM; Mertens, HDT; Kirb, N; Pham, CLL; Hinds, MG; Adlard, PA; Barnham, KJ; Curtain, CC; Masters, CL